Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients

Bibian M. E. Tullemans, Magdolna Nagy, Siamack Sabrkhany, Arjan W. Griffioen, Mirjam G. A. Oude Egbrink, Maureen Aarts, Johan W. M. Heemskerk, Marijke J. E. Kuijpers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Article number142
Number of pages12
JournalFrontiers in cardiovascular medicine
Volume5
DOIs
Publication statusPublished - 16 Oct 2018

Keywords

  • platelets
  • thrombus
  • tyrosine kinase inhibitor
  • phosphatidylserine
  • pazopanib
  • procoagulant activity
  • THROMBUS FORMATION
  • IN-VIVO
  • GLYCOPROTEIN VI
  • CANCER-PATIENTS
  • KEY ROLE
  • ACTIVATION
  • COLLAGEN
  • SYK
  • RECEPTOR
  • INTEGRIN

Cite this